A carregar...
Impact of Disease and Treatment Response in Drug–Drug Interaction Studies: Osimertinib and Simvastatin in Advanced Non‐Small Cell Lung Cancer
A phase I, open‐label study (NCT02197234) assessed the effects of osimertinib on simvastatin exposure in patients with advanced epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer and disease progression post‐EGFR tyrosine kinase inhibitor treatment. Here, we report on a retro...
Na minha lista:
| Publicado no: | Clin Transl Sci |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6951454/ https://ncbi.nlm.nih.gov/pubmed/31498564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12688 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|